Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|July 5, 2017
In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosaPablo A Fraile-Ribot, Xavier Mulet, Gabriel Cabot, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2011
AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strainsLaura Zamorano, Thomas M Reeve, Carlos Juan, et al.
International Journal of Medical Microbiology : IJMM|September 14, 2014
Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infectionPablo Martina, Sofía Feliziani, Carlos Juan, et al.
Case Reports in Dentistry|January 23, 2026
Operculectomy Preceding a Mucoepidermoid Carcinoma Development: Case ReportTorres Urbina Claudia Araceli, Liceaga Escalera Carlos Juan, Montoya Pérez Luis Alberto, et al.
Emerging Infectious Diseases|July 31, 2012
VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, SpainEsther Viedma, Carlos Juan, Jennifer Villa, et al.
International Journal of Antimicrobial Agents|December 13, 2016
Understanding the acute inflammatory response to Pseudomonas aeruginosa infection: differences between susceptible and multidrug-resistant strains in a mouse peritonitis modelSilvia Gómez-Zorrilla, Laura Calatayud, Carlos Juan, et al.
International Journal of Antimicrobial Agents|April 16, 2016
Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studiesSilvia Gómez-Zorrilla, Carlos Juan, Gabriel Cabot, et al.
Microbiology Spectrum|July 30, 2025
An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β-lactam resistance in Pseudomonas aeruginosaMaria Escobar-Salom, Isabel M Barceló, Jordi Sansó-Sastre, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2020
In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosaMaría A Gomis-Font, Gabriel Cabot, Irina Sánchez-Diener, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2017
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosaPablo A Fraile-Ribot, Gabriel Cabot, Xavier Mulet, et al.
Pageof 12